HR Intern

Your mission To provide general administrative support on day-to-day HR activities in order to build professional knowledge around common HR processes. Job Description Our global organization is seeking a Human Resources (HR) Intern to work within our small HR team on a part-time basis in our Shoreditch offices. Contributing as an HR Intern, your duties will include a variety of administrative activities that focus around recruitment and onboarding. You will also sit in on regular HR Team meetings and may be involved in other ad hoc HR activities.Include 8-12 main activitiesDescribe ExpectationsJob ResponsibilitiesUpdating company databases by inputting new employee contact information and employment detailsOrganizing interviews with shortlisted candidates.Posting job advertisements on our website and social media platformsPreparing and sending offer letters and contract letters or emails to candidates.Coordinating new hires and the onboarding processResponding to staff inquiries regarding HR policies, employee benefits, and other HR-related matters.Coordinating exit paperwork for offboarding activitiesGenerating basic HR data reporting to be shared across our global teams.Job RequirementsAdministrative work experience at entry level required; working towards an HR qualification is desirable or an interest in Human Resources.Ability to work from the office during the week. About usMeiraGTx is a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases. We currently have six programs in clinical development including three ocular indications, a salivary gland condition, and a Parkinson’s disease program. Our initial focus on diseases of the eye, salivary gland and central nervous system is based on the significant unmet medical need coupled with the high potential gene therapy has to provide meaningful clinical benefit in these areas. With headquarters in New York and London, our global footprint provides us the opportunity to partner with leading institutions around the world, allowing us to deepen our understanding of diseases and their progression.Our team was built with deep expertise in gene therapy development, allowing us to efficiently advance our programs from preclinical to clinical development. Our core capabilities in viral vector design and optimization and gene therapy manufacturing give us a differentiated approach to developing gene therapies. Additionally, we are developing proprietary technology to potentially enable innovative gene therapy treatments whose expression can be turned on and off with an easily administered small molecule. We believe temporal control of gene therapy products has the potential to transform the gene therapy landscape.Our state-of-the-art manufacturing facility, completed in early 2018, was designed to meet global regulatory requirements, including the current good manufacturing practices (cGMP) required by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK and the U.S. Food and Drug Administration (FDA). The 29,000-square foot facility has the flexibility and capacity to produce sufficient product for all our clinical trials and will scale to commercial capacity.